These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease. Nielsen OH; Ciardelli T; Wu Z; Langholz E; Kirman I Am J Gastroenterol; 1995 Aug; 90(8):1301-6. PubMed ID: 7639234 [TBL] [Abstract][Full Text] [Related]
4. Serum interleukin-8 as a serologic marker of activity in Behçet's disease. Gür-Toy G; Lenk N; Yalcin B; Aksaray S; Alli N Int J Dermatol; 2005 Aug; 44(8):657-60. PubMed ID: 16101867 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma. Ihn H; Sato S; Fujimoto M; Kikuchi K; Takehara K Br J Dermatol; 1996 May; 134(5):843-7. PubMed ID: 8736323 [TBL] [Abstract][Full Text] [Related]
6. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease. Evereklioglu C; Er H; Türköz Y; Cekmen M Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429 [TBL] [Abstract][Full Text] [Related]
7. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease. Oztas MO; Onder M; Gurer MA; Bukan N; Sancak B Clin Exp Dermatol; 2005 Jan; 30(1):61-3. PubMed ID: 15663506 [TBL] [Abstract][Full Text] [Related]
8. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease. Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123 [TBL] [Abstract][Full Text] [Related]
9. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy. Dejica D Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973 [TBL] [Abstract][Full Text] [Related]
10. Levels of soluble E-selectin in patients with active Behcet's disease. Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451 [TBL] [Abstract][Full Text] [Related]
12. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity. Turan B; Gallati H; Erdi H; Gürler A; Michel BA; Villiger PM J Rheumatol; 1997 Jan; 24(1):128-32. PubMed ID: 9002023 [TBL] [Abstract][Full Text] [Related]
13. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer. Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351 [TBL] [Abstract][Full Text] [Related]
14. [Soluble IL-2 receptor levels in rheumatic diseases]. Takaya M; Ichikawa Y; Shimizu H; Uchiyama M; Moriuchi J; Arimori S Ryumachi; 1993 Jun; 33(3):229-34. PubMed ID: 8346465 [TBL] [Abstract][Full Text] [Related]
15. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases. Shaarawy M; Darwish NA; Abdel-Aziz O J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806 [TBL] [Abstract][Full Text] [Related]
16. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C. Kitaoka S; Shiota G; Kawasaki H Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788 [TBL] [Abstract][Full Text] [Related]
17. [Usefulness of the measurement of serum soluble IL-2 receptor alpha chain levels in clinical monitoring of non-Hodgkin lymphoma]. Setoyama Y; Imai J; Ishikawa T; Sakaida H; Takaori-Kondo A; Kawamata S; Uchiyama T Rinsho Byori; 1994 Aug; 42(8):834-42. PubMed ID: 7933620 [TBL] [Abstract][Full Text] [Related]
18. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement. Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013 [TBL] [Abstract][Full Text] [Related]
19. [Serum soluble IL-2 receptor level in patients with sarcoidosis]. Ina Y; Takada K; Noda M; Satou T; Hashiba H; Miyachi A; Ito S; Iijima N; Yamamoto M Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Mar; 29(3):316-21. PubMed ID: 2067152 [TBL] [Abstract][Full Text] [Related]